Review of recent trials of chemotherapy for advanced breast cancer: Studies excluding taxanes

This publication has 68 references indexed in Scilit:

• PP-7-12 Dose-finding study of weekly oral vinorelbine (VRL) in patients (PTS) with advanced breast cancer (ABC): preliminary results
  European Journal Of Cancer, 1996
• Salvage chemotherapy in metastatic breast cancer: An experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin
  Breast Cancer Research and Treatment, 1996
• Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients
  Breast Cancer Research and Treatment, 1996
• PP-5-2 Neo-Adjuvant High-Dose FEC Regimen (H-FEC) with G-CSF (G) for Large Early Breast Cancer
  European Journal Of Cancer, 1996
• PP-7-2 Neoadjuvant chemotherapy by VEC regimen in breast cancer. preliminary results of a phase II trial
  European Journal Of Cancer, 1996
• PP-7-9 Weekly vinorelbine (VRB) as single agent for advanced breast cancer (ABC)
  European Journal Of Cancer, 1996
• PP-8-30 MRF (Mitomycin, folinic acid and 5FU) for metastatic breast cancer — A prospective pilot study
  European Journal Of Cancer, 1996
• Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer
  European Journal Of Cancer, 1995
• Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer
  European Journal Of Cancer, 1995
• Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer
  European Journal Of Cancer, 1994